Delivery Order SPE2DB22D2206-SPE2DB25FJF41
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a contract value of $6,506.97 and an ultimate completion date of July 31, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through an open procurement process. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg with a ceiling value of $1,420.42. This firm fixed-price contract, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract utilized no set-aside designation and was awarded competitively. Performance will be executed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a ceiling value of $2,596.57. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of 100 tablets of Ambien CR 6.25 mg with a ceiling value of $6,913.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order valued at $15,429.77 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). This non-competitive, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $4,297.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of July 25, 2025. This non-set-aside award was competitively procured and represents a single delivery order against AmerisourceBergen's larger contract vehicle with DLA. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 at a firm fixed price ceiling value of $8,173.49. This non-set-aside award is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,274.62. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg with a ceiling value of $3,175.13. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a single line item within the federal pharmaceutical supply chain supporting...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJF41Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg, with a ceiling value of $2,512.40. This firm fixed price delivery order, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies. The parent IDC serves as a global pharmaceutical support vehicle, enabling the company to fulfill diverse medical commodity requirements across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/4/25 |